Hemolytic-uremic syndrome secondary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [3]
Secondary Prevention
Secondary Prevention
Effective measures for the secondary prevention of HUS include:[1][2][3]
- Supportive therapy and hydration
- Close observation for worsening clinical status
- Use of eculizumab in atypical HUS
- Avoidance of nephrotoxic medications
References
References
- ↑ Grisaru, Silviu (2014). “Management of hemolytic-uremic syndrome in children”. International Journal of Nephrology and Renovascular Disease: 231. doi:10.2147/IJNRD.S41837. ISSN 1178-7058.
- ↑ Hoon Young Choi & Sung Kyu Ha (2013). “Potassium balances in maintenance hemodialysis”. Electrolyte & blood pressure : E & BP. 11 (1): 9–16. doi:10.5049/EBP.2013.11.1.9. PMID 23946760. Unknown parameter
|month=ignored (help) - ↑ . doi:10.1007/s00467-018-4025-0 Share on FacebookShare on TwitterShare on Google+ Check
|doi=value (help). Missing or empty|title=(help)
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH